May 1994 University of Pennsylvania
Philadelphia, Pennsylvania
B.S.
May 2000 University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania
M.D.
June 2000-2001 University of Texas Health Science Center at Houston
Houston, Texas
Intern - General Surgery
July 2001-June 2005 University of Texas Health Science Center at Houston
Houston, Texas
Resident - Urologic Surgery
June 2005-June 2006 University of Texas Health Science Center at Houston
Houston, Texas
Fellow in Female Urology, Neurology and Urinary Tract Reconstruction
2006-Present Chesapeake Urology Associates Center for Continence
Owings Mills, Maryland
Staff Physician
2007-Present Summit Clinical Research Associates
Owings Mills, Maryland
Sub-Investigator
SCIENTIFIC PRESENTATIONS:
Shapiro, A, Ahrar K, Wood CG, Pisters LL, Matin SF, Preliminary Results of Percutaneous Radio Frequency Ablation for Locally Recurrent of Metastatic Renal Cell Carcinoma, Southwest Section of the American Urologic Association, Podium, Boston 2003.
Shapiro, A, Kamat, A. Diffuse Granulomatous Disease caused by Intravesical Bacillus Calmette-Guerin (BCG) Installation Masquerading as Peritoneal Carcinomatosis, Southwest Section of the American Urological Association, T Leon Howard Pyelogram, Ireland 2004.
CLINICAL RESEARCH EXPERIENCE:
Sub-Investigator
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Fesoterodine as an "Add-On" Therapy in Men with Persistent Overactive Bladder Symptoms Under Monotherapy of Alpha Blocker for Lower Urinary Tract Symptoms.
Sub-Investigator
A Phase II, 16 Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Proof of Concept Study Evaluating the Efficacy and Safety of PF-04383119 for the Treatment of Pain Associated with Interstitial Cystitis.
Sub-Investigator
A 12 Week, Randomized, Double-Blind, Placebo- Controlled, Parallel-Group, Multicenter Trial to Evaluate the Efficacy and Safety of a Fesoterodine Flexible Dose Regimen in Patients with Overactive Bladder.